Market Cap 12.84M
Revenue (ttm) 1.76M
Net Income (ttm) -2.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -123.86%
Debt to Equity Ratio 0.00
Volume 11,000
Avg Vol 20,722
Day's Range N/A - N/A
Shares Out 11.57M
Stochastic %K 31%
Beta 0.51
Analysts Strong Buy
Price Target $5.00

Company Profile

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 561 961 1900
Address:
951 Yamato Road, Suite 220, Boca Raton, United States
h8ster
h8ster Sep. 12 at 9:20 PM
$TXMD Mayne now motioning for the judge to allow them oral arguments to dismiss TXMD's case, as the judge seems to be taking his time with his decision. They are worried. LMAOF. Hope Mayne gets destroyed.
1 · Reply
YPOJOB
YPOJOB Sep. 11 at 9:30 PM
$TXMD The validity of Cosette's termination attempts is set for a Supreme Court hearing starting September 22, 2025, leaving the outcome uncertain. The other cases I think need to be completed before this happens. I am not a guru on this. But it would make sense
0 · Reply
h8ster
h8ster Sep. 9 at 7:40 PM
$TXMD On the 8th, TXMD filed their final arguments against Mayne's arguments not to dismiss their claims. Now it is in the hands of the judge to decide if Mayne's countersuit against TXMD is to be dismissed. On the 5th, Mayne filed their final argument against TXMD's arguments not to dismiss their claims. Now that is in the hands of the judge to decide if TXMD's suit against Mayne is to be dismissed. Both cases are in the hands of Judge Richard G. Andrews. He's gotta be like, "WTF"
2 · Reply
JJYLT
JJYLT Sep. 8 at 10:25 AM
$TXMD ⌚️
0 · Reply
jfer333
jfer333 Sep. 6 at 1:09 AM
🚨 $TXMD Legal Update – 9/5 Filing TXMD just filed new legal authority arguing the court — not BDO — should decide the dispute with Mayne. They cite a new ruling (Aztar v. PKN) from the same Delaware court showing that when there’s disagreement about arbitration, the judge must decide — not an outside expert. ⚖️ If the judge agrees, TXMD stays in court & keeps leverage. This would derail Mayne’s motion to delay the case. Rubric likely supports this push for full trial.
0 · Reply
jfer333
jfer333 Aug. 30 at 3:13 AM
🚨 $TXMD Update – Court Filing 8/29 TXMD & Mayne just submitted a joint litigation schedule — signaling they’re preparing for full discovery & trial if the judge denies Mayne’s motion to stay. 🗓️ Key dates proposed: • Answer due: 14 days after ruling • Discovery begins: 21 days after ruling • Expert reports due: Mar–May 2026 • Case ready for trial: Late 2026 ⚖️ Significance: Court hasn’t ruled yet, but this shows TXMD is pushing forward, and both sides are gearing up for a serious legal fight. TXMD is looking to jam up the Cosette/Mayne merger for over a year. This has serious legal cost implications for Mayne and potential delays to their existing merger. Looks like TXMD is forcing these guys to open their check book. The lawsuit is for $11M. Legal costs could be as much as $3M for all parties.
2 · Reply
jfer333
jfer333 Aug. 28 at 6:44 PM
$TXMD I see this as very low risk at these levels regardless of lawsuit outcome. Worst case scenario Rubric takes it private since they are now listed as the parent company , and it would be more than the current market cap of $16M They’re controlling this stock price and not letting it fall below $1 for obvious reasons. I own over 1% of the entire company at $1.20 and have very high conviction on a positive outcome for shareholders at these levels.
2 · Reply
YPOJOB
YPOJOB Aug. 27 at 1:27 AM
$TXMD I thought buyout by now 3-5 range. Hopium was 10. Of course, I want much higher. What are the odds Cossette just buys TXMD? Skip the bullcrap courts. Settle it and move on. ... stalled money doesn't make money
0 · Reply
JJYLT
JJYLT Aug. 26 at 8:46 PM
$TXMD 👀
0 · Reply
ekraus
ekraus Aug. 23 at 1:59 AM
$TXMD things still pretty grim here i see about s year or 2 ago a buyout offer of $10 a share was rejected by stockholders...... smart huh?
0 · Reply
Latest News on TXMD
TherapeuticsMD Announces Second Quarter 2025 Financial Results

Aug 12, 2025, 4:05 PM EDT - 4 weeks ago

TherapeuticsMD Announces Second Quarter 2025 Financial Results


TherapeuticsMD Announces First Quarter 2025 Financial Results

May 13, 2025, 4:05 PM EDT - 4 months ago

TherapeuticsMD Announces First Quarter 2025 Financial Results


TherapeuticsMD Announces Full Year 2024 Financial Results

Mar 27, 2025, 4:05 PM EDT - 6 months ago

TherapeuticsMD Announces Full Year 2024 Financial Results


TherapeuticsMD Announces Third Quarter 2024 Financial Results

Nov 12, 2024, 4:05 PM EST - 10 months ago

TherapeuticsMD Announces Third Quarter 2024 Financial Results


TherapeuticsMD Announces First Quarter 2024 Financial Results

May 10, 2024, 4:05 PM EDT - 1 year ago

TherapeuticsMD Announces First Quarter 2024 Financial Results


TherapeuticsMD Announces Full Year 2023 Financial Results

Mar 29, 2024, 4:00 PM EDT - 1 year ago

TherapeuticsMD Announces Full Year 2023 Financial Results


TherapeuticsMD Announces Third Quarter 2023 Financial Results

Nov 14, 2023, 4:05 PM EST - 1 year ago

TherapeuticsMD Announces Third Quarter 2023 Financial Results


TherapeuticsMD Announces Second Quarter 2023 Financial Results

Aug 14, 2023, 6:50 AM EDT - 2 years ago

TherapeuticsMD Announces Second Quarter 2023 Financial Results


TherapeuticsMD: From Fallen And Forgotten To Cash Cow

May 23, 2023, 9:00 AM EDT - 2 years ago

TherapeuticsMD: From Fallen And Forgotten To Cash Cow


TherapeuticsMD Announces First Quarter 2023 Financial Results

May 15, 2023, 4:05 PM EDT - 2 years ago

TherapeuticsMD Announces First Quarter 2023 Financial Results


TherapeuticsMD Announces Third Quarter 2022 Financial Results

Nov 14, 2022, 4:05 PM EST - 3 years ago

TherapeuticsMD Announces Third Quarter 2022 Financial Results


TherapeuticsMD Announces $7 Million Private Placement

Oct 3, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces $7 Million Private Placement


TherapeuticsMD Announces Second Quarter 2022 Financial Results

Aug 15, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces Second Quarter 2022 Financial Results


Why TherapeuticsMD Shares Are Sinking Today?

Jul 13, 2022, 9:59 AM EDT - 3 years ago

Why TherapeuticsMD Shares Are Sinking Today?


TherapeuticsMD's stock falls 41% after tender offer expires

Jul 13, 2022, 8:25 AM EDT - 3 years ago

TherapeuticsMD's stock falls 41% after tender offer expires


TherapeuticsMD Announces Expiration of Tender Offer

Jul 13, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces Expiration of Tender Offer


Here is why TherapeuticsMD jumped 300%

May 31, 2022, 1:57 PM EDT - 3 years ago

Here is why TherapeuticsMD jumped 300%


Why TherapeuticsMD Stock Is Soaring Today

May 31, 2022, 10:12 AM EDT - 3 years ago

Why TherapeuticsMD Stock Is Soaring Today


Why TherapeuticsMD Shares Are Trading Higher Today

May 20, 2022, 10:54 AM EDT - 3 years ago

Why TherapeuticsMD Shares Are Trading Higher Today


TherapeuticsMD Announces First Quarter 2022 Financial Results

May 16, 2022, 4:05 PM EDT - 3 years ago

TherapeuticsMD Announces First Quarter 2022 Financial Results


TherapeuticsMD Announces Fourth Quarter 2021 Financial Results

Mar 10, 2022, 6:50 AM EST - 3 years ago

TherapeuticsMD Announces Fourth Quarter 2021 Financial Results


Why TherapeuticsMD Shares Are Soaring Today

Mar 7, 2022, 9:38 AM EST - 3 years ago

Why TherapeuticsMD Shares Are Soaring Today


h8ster
h8ster Sep. 12 at 9:20 PM
$TXMD Mayne now motioning for the judge to allow them oral arguments to dismiss TXMD's case, as the judge seems to be taking his time with his decision. They are worried. LMAOF. Hope Mayne gets destroyed.
1 · Reply
YPOJOB
YPOJOB Sep. 11 at 9:30 PM
$TXMD The validity of Cosette's termination attempts is set for a Supreme Court hearing starting September 22, 2025, leaving the outcome uncertain. The other cases I think need to be completed before this happens. I am not a guru on this. But it would make sense
0 · Reply
h8ster
h8ster Sep. 9 at 7:40 PM
$TXMD On the 8th, TXMD filed their final arguments against Mayne's arguments not to dismiss their claims. Now it is in the hands of the judge to decide if Mayne's countersuit against TXMD is to be dismissed. On the 5th, Mayne filed their final argument against TXMD's arguments not to dismiss their claims. Now that is in the hands of the judge to decide if TXMD's suit against Mayne is to be dismissed. Both cases are in the hands of Judge Richard G. Andrews. He's gotta be like, "WTF"
2 · Reply
JJYLT
JJYLT Sep. 8 at 10:25 AM
$TXMD ⌚️
0 · Reply
jfer333
jfer333 Sep. 6 at 1:09 AM
🚨 $TXMD Legal Update – 9/5 Filing TXMD just filed new legal authority arguing the court — not BDO — should decide the dispute with Mayne. They cite a new ruling (Aztar v. PKN) from the same Delaware court showing that when there’s disagreement about arbitration, the judge must decide — not an outside expert. ⚖️ If the judge agrees, TXMD stays in court & keeps leverage. This would derail Mayne’s motion to delay the case. Rubric likely supports this push for full trial.
0 · Reply
jfer333
jfer333 Aug. 30 at 3:13 AM
🚨 $TXMD Update – Court Filing 8/29 TXMD & Mayne just submitted a joint litigation schedule — signaling they’re preparing for full discovery & trial if the judge denies Mayne’s motion to stay. 🗓️ Key dates proposed: • Answer due: 14 days after ruling • Discovery begins: 21 days after ruling • Expert reports due: Mar–May 2026 • Case ready for trial: Late 2026 ⚖️ Significance: Court hasn’t ruled yet, but this shows TXMD is pushing forward, and both sides are gearing up for a serious legal fight. TXMD is looking to jam up the Cosette/Mayne merger for over a year. This has serious legal cost implications for Mayne and potential delays to their existing merger. Looks like TXMD is forcing these guys to open their check book. The lawsuit is for $11M. Legal costs could be as much as $3M for all parties.
2 · Reply
jfer333
jfer333 Aug. 28 at 6:44 PM
$TXMD I see this as very low risk at these levels regardless of lawsuit outcome. Worst case scenario Rubric takes it private since they are now listed as the parent company , and it would be more than the current market cap of $16M They’re controlling this stock price and not letting it fall below $1 for obvious reasons. I own over 1% of the entire company at $1.20 and have very high conviction on a positive outcome for shareholders at these levels.
2 · Reply
YPOJOB
YPOJOB Aug. 27 at 1:27 AM
$TXMD I thought buyout by now 3-5 range. Hopium was 10. Of course, I want much higher. What are the odds Cossette just buys TXMD? Skip the bullcrap courts. Settle it and move on. ... stalled money doesn't make money
0 · Reply
JJYLT
JJYLT Aug. 26 at 8:46 PM
$TXMD 👀
0 · Reply
ekraus
ekraus Aug. 23 at 1:59 AM
$TXMD things still pretty grim here i see about s year or 2 ago a buyout offer of $10 a share was rejected by stockholders...... smart huh?
0 · Reply
Kobe2324
Kobe2324 Aug. 22 at 12:17 PM
$TXMD I have a suspicion that we were pinned at that 1.5 for a reason. I think discussion were moving along for a compromise and purchase of txmd. But it fell thru. Pin it at 1.5 and sell for 3 bucks is my guess.
0 · Reply
h8ster
h8ster Aug. 21 at 7:31 PM
$TXMD So, as of right now, for the Mayne Vs. TXMD case, Mayne's response brief, to TXMD's motion and argument to dismiss Mayne's countersuit, remains unknown. Mayne's brief, arguing for their case not to be dismissed was due last Friday as so ordered by the judge. It could be that the court is simply late in filing the results, or Mayne filed for an extension....again and the judge is weighing the request. With the TXMD vs Mayne case, Mayne filed a motion for dismissal and the judge gave TXMD until last August 5th to respond. There has been no update on that from the courts. Mayne has been shifting lawyers in and out throughout. So many things could be going on. One cause could be stayed pending outcome of the other, gone to arbitration, etc. But the transparency of the court seems to have shut down with lack of /late filings. Neither case is going anywhere, as of now. My best guess is that Mayne is delaying the proceedings until the Cosette BO is ruled on in September
1 · Reply
YPOJOB
YPOJOB Aug. 14 at 1:41 AM
$TXMD TherapeuticsMD (TXMD) announced their latest earnings for Q2 2025 on August 12, 2025. They reported a net income of $551,000, with an earnings per share (EPS) of $0.05, a significant improvement from a loss of -$0.09 per share in Q2 2024. Revenue for the quarter was $952,000, up 327.35% from $234,000 in the same period last year.
0 · Reply
ayan116
ayan116 Aug. 13 at 5:15 PM
$TXMD 2Q earnings came out yesterday
0 · Reply
d_risk
d_risk Aug. 13 at 5:47 AM
$TXMD - TherapeuticsMD, Inc. - 10Q - Updated Risk Factors TXMD flags heightened risk from ongoing legal battles with Mayne Pharma over rebates and returns, warning of possible material hits to revenue, operations, and financial health. #Pharmaceuticals #FinancialHealth #OperationalRisk #RevenueImpact #LegalRisk 🟢 Added 🟠 Removed https://d-risk.ai/TXMD/10-Q/2025-08-12
0 · Reply
YPOJOB
YPOJOB Aug. 12 at 3:28 PM
$TXMD I truly thought we would get a solution here soon. Has anybody seen any news lately?
1 · Reply
BigBrainProfit
BigBrainProfit Aug. 11 at 12:06 AM
$BTAI Same play as SLNO when they had their phase 3 positive readouts, their shares jumped from 3 dollars to 31 instantly in a day and steady climb there after. They also had the only FDA approved treatment but for a much smaller market than BTAIs at home market would be, which is valued at 3b not including alzhimers and over 7b including alzhimers. Its blockbuster potential. Use AI and do your own research. This one is an easy 50x for me. Especially since the phase 3 readout is projected to be next week anx theyve already telegraphed that itll be positive. They passed 2 independant safety reviews on it. Easy 50x $PLTR $IXHL $TXMD
2 · Reply
ekraus
ekraus Aug. 9 at 11:31 AM
$TXMD what happened to $1.40???
0 · Reply
vijalp9
vijalp9 Aug. 8 at 3:33 AM
$TXMD Knight TX quarterly report -- solid growth. Shame they don't publish Bijuva #'s too
1 · Reply
Bio_Invest101
Bio_Invest101 Aug. 4 at 7:56 PM
$TXMD Tang and Xoma have been very busy hunting down the small biotechs. Not sure what/when Rubric could let this whole ordeal go. https://www.fiercebiotech.com/biotech/xoma-goes-shopping-struggling-biotechs-picking-hillevax-and-lava Xoma shops for struggling biotechs, buying HilleVax and Lava
0 · Reply
Kobe2324
Kobe2324 Aug. 4 at 4:20 PM
$TXMD I could really use this transaction money, get it finished
1 · Reply
mwhite9869
mwhite9869 Jul. 31 at 11:17 PM
$TXMD someone do the math for me. If outstanding shares end up sold at $10, what would the existing share price be?
1 · Reply